Physiomics PLC (PYC) RNS Announcements

Date	Time	Date	TitleTitle (filtered)	Source
18/12/15	10:57:21	18 Dec 2015	Placing	Placing	RNS
14/12/15	10:29:15	14 Dec 2015	Result of General Meeting	Result of General Meeting	RNS
04/12/15	11:38:59	4 Dec 2015	Result of AGM	Result of AGM	RNS
27/11/15	16:15:39	27 Nov 2015	Notice of General Meeting	Notice of General Meeting	RNS
10/11/15	07:00:05	10 Nov 2015	Final Results	Final Results	RNS
06/11/15	07:00:09	6 Nov 2015	Strategic Update	Strategic Update	RNS
12/10/15	08:00:13	12 Oct 2015	4th Large Pharma Customer for Virtual Tumour	4th Large Pharma Customer for Virtual Tumour	RNS
09/10/15	08:00:07	9 Oct 2015	Project extension with global pharma company	Project extension with global pharma company	RNS
04/08/15	08:01:01	4 Aug 2015	Prof. Mark Middleton appointed to Physiomics SAB	Prof. Mark Middleton appointed to Physiomics SAB	RNS
29/04/15	17:27:51	29 Apr 2015	Holding(s) in Company	Holding(s) in Company	RNS
26/03/15	07:00:41	26 Mar 2015	Issue of Options	Issue of Options	RNS
17/03/15	07:00:42	17 Mar 2015	Half Yearly Report	Half Yearly Report	RNS
12/03/15	07:00:14	12 Mar 2015	Issue of Equity	Issue of Equity	RNS
06/03/15	13:40:44	6 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
04/03/15	11:56:46	4 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
03/03/15	12:57:10	3 Mar 2015	First contract for clinical version of Virtu	First contract for clinical version of Virtu	RNS
20/02/15	12:34:54	20 Feb 2015	Holding(s) in Company	Holding(s) in Company	RNS
02/02/15	07:00:28	2 Feb 2015	Termination of Equity Swap Agreement	Termination of Equity Swap Agreement	RNS
15/12/14	13:08:04	15 Dec 2014	Result of AGM	Result of AGM	RNS
12/11/14	10:24:12	12 Nov 2014	Final Results	Final Results	RNS
04/11/14	07:00:19	4 Nov 2014	Disclosure of Large Pharma partner Merck & Co	Disclosure of Large Pharma partner Merck & Co	RNS
27/10/14	10:07:37	27 Oct 2014	Project extension with global pharma company	Project extension with global pharma company	RNS
13/10/14	17:43:46	13 Oct 2014	Holding(s) in Company	Holding(s) in Company	RNS
07/10/14	10:35:24	7 Oct 2014	Cardiotox Platform Launch	Cardiotox Platform Launch	RNS
29/08/14	15:47:28	29 Aug 2014	Holding(s) in Company	Holding(s) in Company	RNS
14/08/14	14:10:30	14 Aug 2014	New deal with global pharma	New deal with global pharma	RNS
24/07/14	13:59:51	24 Jul 2014	Issue of Equity	Issue of Equity	RNS
26/06/14	08:57:57	26 Jun 2014	Holding(s) in Company	Holding(s) in Company	RNS
12/06/14	08:00:13	12 Jun 2014	Anticipated new collaboration with Diatech	Anticipated new collaboration with Diatech	RNS
20/05/14	10:47:31	20 May 2014	Holding(s) in Company	Holding(s) in Company	RNS
10/04/14	08:00:29	10 Apr 2014	Second validation of Virtual Tumour Clinical	Second validation of Virtual Tumour Clinical	RNS
03/04/14	08:00:09	3 Apr 2014	Virtual Tumour Clinical Validation	Virtual Tumour Clinical Validation	RNS
14/02/14	07:00:05	14 Feb 2014	Half Yearly Report	Half Yearly Report	RNS
30/01/14	16:41:24	30 Jan 2014	Issue of Equity - Replacement	Issue of Equity - Replacement	RNS
30/01/14	15:02:53	30 Jan 2014	Issue of Equity	Issue of Equity	RNS
17/12/13	14:07:23	17 Dec 2013	Result of AGM	Result of AGM	RNS
04/12/13	10:47:09	4 Dec 2013	Virtual Tumour Proposal	Virtual Tumour Proposal	RNS
28/11/13	13:24:53	28 Nov 2013	DrugCARD launch	DrugCARD launch	RNS
15/11/13	07:00:06	15 Nov 2013	Final Results	Final Results	RNS
11/11/13	07:00:08	11 Nov 2013	University of Oxford Collaboration	University of Oxford Collaboration	RNS
10/10/13	11:30:59	10 Oct 2013	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	RNS
07/10/13	09:32:29	7 Oct 2013	Physiomics gains new speciality pharma customer	Physiomics gains new speciality pharma customer	RNS
26/07/13	14:30:57	26 Jul 2013	Issue of Equity	Issue of Equity	RNS
01/07/13	08:00:07	1 Jul 2013	Additional SEDA Drawdown	Additional SEDA Drawdown	RNS
20/06/13	17:28:36	20 Jun 2013	Award of Grant	Award of Grant	RNS
06/06/13	08:00:05	6 Jun 2013	Virtual Tumour Clinical Contract	Virtual Tumour Clinical Contract	RNS
13/02/13	11:10:30	13 Feb 2013	Issue of Options	Issue of Options	RNS
11/02/13	15:23:35	11 Feb 2013	Director Declaration	Director Declaration	RNS
08/02/13	07:00:08	8 Feb 2013	Half Yearly Report	Half Yearly Report	RNS
22/01/13	07:00:06	22 Jan 2013	SEDA Arrangement	SEDA Arrangement	RNS

Showing 301–350 of 350 announcements

Date	Time	Date	TitleTitle (filtered)	Source
18/12/15	10:57:21	18 Dec 2015	Placing	Placing	RNS
14/12/15	10:29:15	14 Dec 2015	Result of General Meeting	Result of General Meeting	RNS
04/12/15	11:38:59	4 Dec 2015	Result of AGM	Result of AGM	RNS
27/11/15	16:15:39	27 Nov 2015	Notice of General Meeting	Notice of General Meeting	RNS
10/11/15	07:00:05	10 Nov 2015	Final Results	Final Results	RNS
06/11/15	07:00:09	6 Nov 2015	Strategic Update	Strategic Update	RNS
12/10/15	08:00:13	12 Oct 2015	4th Large Pharma Customer for Virtual Tumour	4th Large Pharma Customer for Virtual Tumour	RNS
09/10/15	08:00:07	9 Oct 2015	Project extension with global pharma company	Project extension with global pharma company	RNS
04/08/15	08:01:01	4 Aug 2015	Prof. Mark Middleton appointed to Physiomics SAB	Prof. Mark Middleton appointed to Physiomics SAB	RNS
29/04/15	17:27:51	29 Apr 2015	Holding(s) in Company	Holding(s) in Company	RNS
26/03/15	07:00:41	26 Mar 2015	Issue of Options	Issue of Options	RNS
17/03/15	07:00:42	17 Mar 2015	Half Yearly Report	Half Yearly Report	RNS
12/03/15	07:00:14	12 Mar 2015	Issue of Equity	Issue of Equity	RNS
06/03/15	13:40:44	6 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
04/03/15	11:56:46	4 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
03/03/15	12:57:10	3 Mar 2015	First contract for clinical version of Virtu	First contract for clinical version of Virtu	RNS
20/02/15	12:34:54	20 Feb 2015	Holding(s) in Company	Holding(s) in Company	RNS
02/02/15	07:00:28	2 Feb 2015	Termination of Equity Swap Agreement	Termination of Equity Swap Agreement	RNS
15/12/14	13:08:04	15 Dec 2014	Result of AGM	Result of AGM	RNS
12/11/14	10:24:12	12 Nov 2014	Final Results	Final Results	RNS
04/11/14	07:00:19	4 Nov 2014	Disclosure of Large Pharma partner Merck & Co	Disclosure of Large Pharma partner Merck & Co	RNS
27/10/14	10:07:37	27 Oct 2014	Project extension with global pharma company	Project extension with global pharma company	RNS
13/10/14	17:43:46	13 Oct 2014	Holding(s) in Company	Holding(s) in Company	RNS
07/10/14	10:35:24	7 Oct 2014	Cardiotox Platform Launch	Cardiotox Platform Launch	RNS
29/08/14	15:47:28	29 Aug 2014	Holding(s) in Company	Holding(s) in Company	RNS
14/08/14	14:10:30	14 Aug 2014	New deal with global pharma	New deal with global pharma	RNS
24/07/14	13:59:51	24 Jul 2014	Issue of Equity	Issue of Equity	RNS
26/06/14	08:57:57	26 Jun 2014	Holding(s) in Company	Holding(s) in Company	RNS
12/06/14	08:00:13	12 Jun 2014	Anticipated new collaboration with Diatech	Anticipated new collaboration with Diatech	RNS
20/05/14	10:47:31	20 May 2014	Holding(s) in Company	Holding(s) in Company	RNS
10/04/14	08:00:29	10 Apr 2014	Second validation of Virtual Tumour Clinical	Second validation of Virtual Tumour Clinical	RNS
03/04/14	08:00:09	3 Apr 2014	Virtual Tumour Clinical Validation	Virtual Tumour Clinical Validation	RNS
14/02/14	07:00:05	14 Feb 2014	Half Yearly Report	Half Yearly Report	RNS
30/01/14	16:41:24	30 Jan 2014	Issue of Equity - Replacement	Issue of Equity - Replacement	RNS
30/01/14	15:02:53	30 Jan 2014	Issue of Equity	Issue of Equity	RNS
17/12/13	14:07:23	17 Dec 2013	Result of AGM	Result of AGM	RNS
04/12/13	10:47:09	4 Dec 2013	Virtual Tumour Proposal	Virtual Tumour Proposal	RNS
28/11/13	13:24:53	28 Nov 2013	DrugCARD launch	DrugCARD launch	RNS
15/11/13	07:00:06	15 Nov 2013	Final Results	Final Results	RNS
11/11/13	07:00:08	11 Nov 2013	University of Oxford Collaboration	University of Oxford Collaboration	RNS
10/10/13	11:30:59	10 Oct 2013	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	RNS
07/10/13	09:32:29	7 Oct 2013	Physiomics gains new speciality pharma customer	Physiomics gains new speciality pharma customer	RNS
26/07/13	14:30:57	26 Jul 2013	Issue of Equity	Issue of Equity	RNS
01/07/13	08:00:07	1 Jul 2013	Additional SEDA Drawdown	Additional SEDA Drawdown	RNS
20/06/13	17:28:36	20 Jun 2013	Award of Grant	Award of Grant	RNS
06/06/13	08:00:05	6 Jun 2013	Virtual Tumour Clinical Contract	Virtual Tumour Clinical Contract	RNS
13/02/13	11:10:30	13 Feb 2013	Issue of Options	Issue of Options	RNS
11/02/13	15:23:35	11 Feb 2013	Director Declaration	Director Declaration	RNS
08/02/13	07:00:08	8 Feb 2013	Half Yearly Report	Half Yearly Report	RNS
22/01/13	07:00:06	22 Jan 2013	SEDA Arrangement	SEDA Arrangement	RNS

Showing 301–350 of 350 announcements

Date	Time	Date	TitleTitle (filtered)	Source
18/12/15	10:57:21	18 Dec 2015	Placing	Placing	RNS
14/12/15	10:29:15	14 Dec 2015	Result of General Meeting	Result of General Meeting	RNS
04/12/15	11:38:59	4 Dec 2015	Result of AGM	Result of AGM	RNS
27/11/15	16:15:39	27 Nov 2015	Notice of General Meeting	Notice of General Meeting	RNS
10/11/15	07:00:05	10 Nov 2015	Final Results	Final Results	RNS
06/11/15	07:00:09	6 Nov 2015	Strategic Update	Strategic Update	RNS
12/10/15	08:00:13	12 Oct 2015	4th Large Pharma Customer for Virtual Tumour	4th Large Pharma Customer for Virtual Tumour	RNS
09/10/15	08:00:07	9 Oct 2015	Project extension with global pharma company	Project extension with global pharma company	RNS
04/08/15	08:01:01	4 Aug 2015	Prof. Mark Middleton appointed to Physiomics SAB	Prof. Mark Middleton appointed to Physiomics SAB	RNS
29/04/15	17:27:51	29 Apr 2015	Holding(s) in Company	Holding(s) in Company	RNS
26/03/15	07:00:41	26 Mar 2015	Issue of Options	Issue of Options	RNS
17/03/15	07:00:42	17 Mar 2015	Half Yearly Report	Half Yearly Report	RNS
12/03/15	07:00:14	12 Mar 2015	Issue of Equity	Issue of Equity	RNS
06/03/15	13:40:44	6 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
04/03/15	11:56:46	4 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
03/03/15	12:57:10	3 Mar 2015	First contract for clinical version of Virtu	First contract for clinical version of Virtu	RNS
20/02/15	12:34:54	20 Feb 2015	Holding(s) in Company	Holding(s) in Company	RNS
02/02/15	07:00:28	2 Feb 2015	Termination of Equity Swap Agreement	Termination of Equity Swap Agreement	RNS
15/12/14	13:08:04	15 Dec 2014	Result of AGM	Result of AGM	RNS
12/11/14	10:24:12	12 Nov 2014	Final Results	Final Results	RNS
04/11/14	07:00:19	4 Nov 2014	Disclosure of Large Pharma partner Merck & Co	Disclosure of Large Pharma partner Merck & Co	RNS
27/10/14	10:07:37	27 Oct 2014	Project extension with global pharma company	Project extension with global pharma company	RNS
13/10/14	17:43:46	13 Oct 2014	Holding(s) in Company	Holding(s) in Company	RNS
07/10/14	10:35:24	7 Oct 2014	Cardiotox Platform Launch	Cardiotox Platform Launch	RNS
29/08/14	15:47:28	29 Aug 2014	Holding(s) in Company	Holding(s) in Company	RNS
14/08/14	14:10:30	14 Aug 2014	New deal with global pharma	New deal with global pharma	RNS
24/07/14	13:59:51	24 Jul 2014	Issue of Equity	Issue of Equity	RNS
26/06/14	08:57:57	26 Jun 2014	Holding(s) in Company	Holding(s) in Company	RNS
12/06/14	08:00:13	12 Jun 2014	Anticipated new collaboration with Diatech	Anticipated new collaboration with Diatech	RNS
20/05/14	10:47:31	20 May 2014	Holding(s) in Company	Holding(s) in Company	RNS
10/04/14	08:00:29	10 Apr 2014	Second validation of Virtual Tumour Clinical	Second validation of Virtual Tumour Clinical	RNS
03/04/14	08:00:09	3 Apr 2014	Virtual Tumour Clinical Validation	Virtual Tumour Clinical Validation	RNS
14/02/14	07:00:05	14 Feb 2014	Half Yearly Report	Half Yearly Report	RNS
30/01/14	16:41:24	30 Jan 2014	Issue of Equity - Replacement	Issue of Equity - Replacement	RNS
30/01/14	15:02:53	30 Jan 2014	Issue of Equity	Issue of Equity	RNS
17/12/13	14:07:23	17 Dec 2013	Result of AGM	Result of AGM	RNS
04/12/13	10:47:09	4 Dec 2013	Virtual Tumour Proposal	Virtual Tumour Proposal	RNS
28/11/13	13:24:53	28 Nov 2013	DrugCARD launch	DrugCARD launch	RNS
15/11/13	07:00:06	15 Nov 2013	Final Results	Final Results	RNS
11/11/13	07:00:08	11 Nov 2013	University of Oxford Collaboration	University of Oxford Collaboration	RNS
10/10/13	11:30:59	10 Oct 2013	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	RNS
07/10/13	09:32:29	7 Oct 2013	Physiomics gains new speciality pharma customer	Physiomics gains new speciality pharma customer	RNS
26/07/13	14:30:57	26 Jul 2013	Issue of Equity	Issue of Equity	RNS
01/07/13	08:00:07	1 Jul 2013	Additional SEDA Drawdown	Additional SEDA Drawdown	RNS
20/06/13	17:28:36	20 Jun 2013	Award of Grant	Award of Grant	RNS
06/06/13	08:00:05	6 Jun 2013	Virtual Tumour Clinical Contract	Virtual Tumour Clinical Contract	RNS
13/02/13	11:10:30	13 Feb 2013	Issue of Options	Issue of Options	RNS
11/02/13	15:23:35	11 Feb 2013	Director Declaration	Director Declaration	RNS
08/02/13	07:00:08	8 Feb 2013	Half Yearly Report	Half Yearly Report	RNS
22/01/13	07:00:06	22 Jan 2013	SEDA Arrangement	SEDA Arrangement	RNS

Showing 301–350 of 350 announcements

Date	Time	Date	TitleTitle (filtered)	Source
18/12/15	10:57:21	18 Dec 2015	Placing	Placing	RNS
14/12/15	10:29:15	14 Dec 2015	Result of General Meeting	Result of General Meeting	RNS
04/12/15	11:38:59	4 Dec 2015	Result of AGM	Result of AGM	RNS
27/11/15	16:15:39	27 Nov 2015	Notice of General Meeting	Notice of General Meeting	RNS
10/11/15	07:00:05	10 Nov 2015	Final Results	Final Results	RNS
06/11/15	07:00:09	6 Nov 2015	Strategic Update	Strategic Update	RNS
12/10/15	08:00:13	12 Oct 2015	4th Large Pharma Customer for Virtual Tumour	4th Large Pharma Customer for Virtual Tumour	RNS
09/10/15	08:00:07	9 Oct 2015	Project extension with global pharma company	Project extension with global pharma company	RNS
04/08/15	08:01:01	4 Aug 2015	Prof. Mark Middleton appointed to Physiomics SAB	Prof. Mark Middleton appointed to Physiomics SAB	RNS
29/04/15	17:27:51	29 Apr 2015	Holding(s) in Company	Holding(s) in Company	RNS
26/03/15	07:00:41	26 Mar 2015	Issue of Options	Issue of Options	RNS
17/03/15	07:00:42	17 Mar 2015	Half Yearly Report	Half Yearly Report	RNS
12/03/15	07:00:14	12 Mar 2015	Issue of Equity	Issue of Equity	RNS
06/03/15	13:40:44	6 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
04/03/15	11:56:46	4 Mar 2015	Holding(s) in Company	Holding(s) in Company	RNS
03/03/15	12:57:10	3 Mar 2015	First contract for clinical version of Virtu	First contract for clinical version of Virtu	RNS
20/02/15	12:34:54	20 Feb 2015	Holding(s) in Company	Holding(s) in Company	RNS
02/02/15	07:00:28	2 Feb 2015	Termination of Equity Swap Agreement	Termination of Equity Swap Agreement	RNS
15/12/14	13:08:04	15 Dec 2014	Result of AGM	Result of AGM	RNS
12/11/14	10:24:12	12 Nov 2014	Final Results	Final Results	RNS
04/11/14	07:00:19	4 Nov 2014	Disclosure of Large Pharma partner Merck & Co	Disclosure of Large Pharma partner Merck & Co	RNS
27/10/14	10:07:37	27 Oct 2014	Project extension with global pharma company	Project extension with global pharma company	RNS
13/10/14	17:43:46	13 Oct 2014	Holding(s) in Company	Holding(s) in Company	RNS
07/10/14	10:35:24	7 Oct 2014	Cardiotox Platform Launch	Cardiotox Platform Launch	RNS
29/08/14	15:47:28	29 Aug 2014	Holding(s) in Company	Holding(s) in Company	RNS
14/08/14	14:10:30	14 Aug 2014	New deal with global pharma	New deal with global pharma	RNS
24/07/14	13:59:51	24 Jul 2014	Issue of Equity	Issue of Equity	RNS
26/06/14	08:57:57	26 Jun 2014	Holding(s) in Company	Holding(s) in Company	RNS
12/06/14	08:00:13	12 Jun 2014	Anticipated new collaboration with Diatech	Anticipated new collaboration with Diatech	RNS
20/05/14	10:47:31	20 May 2014	Holding(s) in Company	Holding(s) in Company	RNS
10/04/14	08:00:29	10 Apr 2014	Second validation of Virtual Tumour Clinical	Second validation of Virtual Tumour Clinical	RNS
03/04/14	08:00:09	3 Apr 2014	Virtual Tumour Clinical Validation	Virtual Tumour Clinical Validation	RNS
14/02/14	07:00:05	14 Feb 2014	Half Yearly Report	Half Yearly Report	RNS
30/01/14	16:41:24	30 Jan 2014	Issue of Equity - Replacement	Issue of Equity - Replacement	RNS
30/01/14	15:02:53	30 Jan 2014	Issue of Equity	Issue of Equity	RNS
17/12/13	14:07:23	17 Dec 2013	Result of AGM	Result of AGM	RNS
04/12/13	10:47:09	4 Dec 2013	Virtual Tumour Proposal	Virtual Tumour Proposal	RNS
28/11/13	13:24:53	28 Nov 2013	DrugCARD launch	DrugCARD launch	RNS
15/11/13	07:00:06	15 Nov 2013	Final Results	Final Results	RNS
11/11/13	07:00:08	11 Nov 2013	University of Oxford Collaboration	University of Oxford Collaboration	RNS
10/10/13	11:30:59	10 Oct 2013	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	Drawdown pursuant to SEDA Arrngmnt/Issue of Equity	RNS
07/10/13	09:32:29	7 Oct 2013	Physiomics gains new speciality pharma customer	Physiomics gains new speciality pharma customer	RNS
26/07/13	14:30:57	26 Jul 2013	Issue of Equity	Issue of Equity	RNS
01/07/13	08:00:07	1 Jul 2013	Additional SEDA Drawdown	Additional SEDA Drawdown	RNS
20/06/13	17:28:36	20 Jun 2013	Award of Grant	Award of Grant	RNS
06/06/13	08:00:05	6 Jun 2013	Virtual Tumour Clinical Contract	Virtual Tumour Clinical Contract	RNS
13/02/13	11:10:30	13 Feb 2013	Issue of Options	Issue of Options	RNS
11/02/13	15:23:35	11 Feb 2013	Director Declaration	Director Declaration	RNS
08/02/13	07:00:08	8 Feb 2013	Half Yearly Report	Half Yearly Report	RNS
22/01/13	07:00:06	22 Jan 2013	SEDA Arrangement	SEDA Arrangement	RNS

Showing 301–350 of 350 announcements

Physiomics PLC RNS

Physiomics PLC RNS